Therefore, status p53 may influence the CD44/CD166 expression level in MFR-surviving NSCLC cells after an acute dose of IR, contributing to a high risk for metastasis with anticipated low patient survival. The gene discussed is CD44; the disease is non-small cell lung carcinoma.